Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 970 across all filing types
Latest filing 2022-04-21 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于召开2021年年度股东大会的提示性公告
AGM Information Classification · 95% confidence The document is titled as a "股东大会提示性公告" which translates to "Shareholders' Meeting Reminder Announcement." It details the notification and procedural information for the 2021 Annual General Meeting (AGM) of the company, including meeting date, voting methods, agenda items, registration procedures, and attachments such as proxy forms and shareholder registration forms. It does not contain the actual meeting materials, minutes, or voting results, but rather serves as a notice or reminder for the upcoming AGM. The document length is about 5653 characters, which is consistent with a detailed announcement but not a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or related to the AGM, especially notices and announcements about the meeting itself.
2022-04-21 Chinese
公司控股股东、实际控制人、董事、监事、高级管理人员买卖公司股份的行为规范
Governance Information Classification · 95% confidence The document is titled '买卖公司股份行为规范' which translates to 'Code of Conduct for Trading Company Shares'. It details rules and regulations governing the buying and selling of company shares by controlling shareholders, actual controllers, directors, supervisors, and senior management personnel. The content includes definitions, restrictions on share trading periods, disclosure requirements, and compliance with relevant laws and stock exchange rules. There is no financial data, earnings information, or report publication mentioned. The document is a governance-related policy outlining internal rules and compliance practices for share transactions by insiders. Therefore, it fits best under Governance Information (CGR). The document length is about 5400 characters, which is sufficient for a detailed policy document rather than a brief announcement or certification.
2022-04-14 Chinese
第三届监事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a Supervisory Board resolution announcement regarding the review and approval of the company's 2022 first quarter report. It states that the Supervisory Board has audited and approved the quarterly report, confirming its compliance with laws and regulations. The document itself does not contain the full quarterly report or detailed financial data but refers readers to the official disclosure website for the full report. The document length is short (926 characters) and serves as an announcement of the Supervisory Board's resolution rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement related to an interim/quarterly report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement about the Supervisory Board's approval of the quarterly report, not the report itself.
2022-04-14 Chinese
2022年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2022 年第一季度报告全文" which translates to "2022 First Quarter Report Full Text." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the first quarter of 2022. The document explicitly states it is a quarterly report and mentions it is unaudited. The length is substantial (over 14,000 characters) and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2022-04-14 Chinese
关于公司取得医疗器械注册变更文件的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company obtaining a change in the registration document for a medical device, specifically a change in the production address for a product. It includes details about the product and the change, and a statement about the impact on the company. The document is short (821 characters) and serves as a formal notification to investors and the public about this regulatory update. It does not contain financial data, management discussion, or detailed report content. It is not a full report but an announcement of a regulatory or compliance update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-04-14 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is titled "信息披露管理制度" which translates to "Information Disclosure Management System" for 烟台正海生物科技股份有限公司. It extensively details the company's policies and procedures for information disclosure, including definitions, legal references, types of reports (annual, semi-annual, quarterly, and interim), disclosure obligations, board and shareholder meeting resolutions, transaction disclosures, and other regulatory compliance matters. It does not contain actual financial statements or results but rather outlines the governance and regulatory framework for disclosures. This type of document is a governance or regulatory compliance manual rather than a financial report or announcement. Therefore, it fits best under the category of Governance Information (CGR). The document length (15,000 characters) and detailed procedural content support this classification with high confidence.
2022-04-14 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.